Both medications, similar to all other GLP-1 weight loss drugs, share similar common side effects, including: Nausea Diarrhea Vomiting Constipation Some early data indicate that retatrutide may have slightly higher rates of certain side effects compared with semaglutide at higher doses because it mimics 3 different hormones and is more potent
Retatrutide targets all three receptors (GLP-1, GIP, and glucagon) simultaneously, and Phase 2 data showed up to 24.2% weight loss at 48 weeks
Diabetic participants who took liraglutide or semaglutide often lost 15% or more of their body weight, a result not seen with other treatments or lifestyle changes alone
For active manufacturing facilities with rapid product turnover, room temperature storage may prove sufficient, though we recommend monitoring batch dates carefully to ensure optimal potency in final formulations
If you eat a large meal while on a high dose, you will feel it
If it is cloudy, discolored, or contains visible particles after 5 minutes of gentle mixing, do not use it
